Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. monaco
  4. therapy evading cancers
Show results for
Products
Services
Software
Training
Applications

Companies


Refine by
Locations
Back to All Locations

  • Europe
  • Monaco
Business Types

  • Manufacturer
  • Technology
  • Software vendor
  • Service provider
  • Research institute
  • Consulting firm
Industries served

  • Medical / Health Care
  • Monitoring and Testing
  • Chemical & Pharmaceuticals
  • Health and Safety
  • Electronics and Computers
  • Environmental
  • Air and Climate
  • Manufacturing, Other
  • Energy
  • Construction & Construction Materials
Employees

  • 101-1000
  • Over 1000

Therapy Evading Cancers Suppliers Serving Monaco

113 companies found
Serving MonacoNear Monaco

Indivumed GmbH

Indivumed GmbH

based inHamburg, GERMANY
Indivumed GmbH was founded in 2002 by leading scientists with a drive to revolutionize cancer treatment through individualized therapy. As a physician-led, integrated global oncology company our experts leverage the world’s premier multi-omics ...
IndivuType - Global Multi-Omics Cancer Database Services

IndivuType - Global Multi-Omics Cancer Database Services

IndivuType uses our highest quality biospecimens and clinical data, combined with leading-edge analytical methods, to offer a unique multi-omics database. Thus, providing new insights into the biology of cancer and enabling new discoveries in the ...
CONTACT SUPPLIER

Reglagene Holding, Inc.

Reglagene Holding, Inc.

based inTucson, ARIZONA (USA)
Novel therapeutics are lacking for Brain Cancer. Only four of the 217 FDA-approved oncology medicines are indicated for life-threatening brain cancers. The most recent approval was in 2009 and did not extend life expectancy. Patients deserve better ...
Reglagene - Novel Therapeutics Lacking for Brain Cancer

Reglagene - Novel Therapeutics Lacking for Brain Cancer

Only 4 of the 217 FDA-approved oncology medicines are indicated for life-threatening brain cancers. The most recent approval was in 2009, but this medicine did not extend life expectancy. Patients deserve better therapies that extend life and ...
CONTACT SUPPLIER

Physiomics Plc

Physiomics Plc

based inOxford, UNITED KINGDOM
Physiomics are a leading oncology consultancy using proprietary state of the art Virtual TumourTM technology and other tools to predict and better understand the effects of cancer treatments. We work with partners developing cancer drugs to help ...
Virtual Tumour - Predictive Modelling Simulation Tool

Virtual Tumour - Predictive Modelling Simulation Tool

Virtual Tumour™ is our advanced, predictive modelling simulation tool used worldwide by global pharmaceuticals to small biotech companies to support oncology ...
CONTACT SUPPLIER

NeoTherma Oncology

NeoTherma Oncology

based inWichita, KANSAS (USA)
Neotherma Oncology is led by experienced healthcare executives who are working toward the dream of more effective treatments for cancer. NeoTherma Oncology is developing a groundbreaking type of radio frequency (RF) thermal treatment for deep solid ...
CONTACT SUPPLIER

Regor Pharmaceuticals Inc.

Regor Pharmaceuticals Inc.

based inCambridge, MASSACHUSETTS (USA)
Founded in 2018 by a team of accomplished scientists with a proven track record in drug discovery and executive leadership in top global biopharmaceutical companies, Regor is a pioneering international biotech company with headquarters in Shanghai, ...
CONTACT SUPPLIER

Biocept

Biocept

based inSan Diego, CALIFORNIA (USA)
We are dedicated to one thing: improving outcomes for cancer patients. That’s why we focus on developing innovative diagnostic solutions that give patients and doctors the information they need—all from a simple blood test, known as a liquid biopsy. ...
CONTACT SUPPLIER

Genmab A/S

Genmab A/S

based inCopenhagen V, DENMARK
Founded in 1999 in Copenhagen, Denmark, we are a dual-listed, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. We are led by an experienced ...
Genmab DuoBody - Model PD-L1x4-1BB (GEN1046) - Proprietary Bispecific Antibody

Genmab DuoBody - Model PD-L1x4-1BB (GEN1046) - Proprietary Bispecific Antibody

DuoBody PD-L1x4-1BB (GEN1046) is a proprietary bispecific antibody, jointly owned by Genmab and BioNTech, created using Genmab’s DuoBody® technology. It is being co-developed by Genmab under an agreement in which the companies share all ...
CONTACT SUPPLIER

Virica Biotech

Virica Biotech

based inOttawa, ONTARIO (CANADA)
Virica was founded in 2018 based on a decade of research in the laboratory of Dr. Jean-Simon Diallo at the Ottawa Hospital Research Institute. Dr. Diallo was investigating novel oncolytic viral therapies (OVTs) and recognized the need for VSEs to ...
CONTACT SUPPLIER

TheraBionic GmbH

TheraBionic GmbH

based inEttlingen, GERMANY
We are a pioneering medical device company focused on transforming the lives of patients with difficult to treat cancers by applying our discoveries in bioelectromagnetics to targeted treatment of cancer. Our patient-based research using low and ...
Therapy of Hepatocellular Carcinoma

Therapy of Hepatocellular Carcinoma

Therapy of HCC depend on the size and location of the tumor, how well the liver is functioning, and the overall health of the patient. ...
CONTACT SUPPLIER

Neutron Therapeutics, Inc.

Neutron Therapeutics, Inc.

based inDanvers, MASSACHUSETTS (USA)
Neutron Therapeutics is a medical equipment company founded in November 2015. We are working to bring Boron Neutron Capture Therapy (BNCT) out of the realm of medical research and transform it into a widely available first-line cancer therapy. We ...
Neutron - Targeted Radiation Therapy Service with BNCT

Neutron - Targeted Radiation Therapy Service with BNCT

A Promising Non-Invasive Therapy for Cancer Patients; Boron Neutron Capture Therapy (BNCT) is a unique type of radiation therapy that enables targeting of cancer at the cellular level. BNCT has been used to treat cancer with a non-invasive two-step ...
CONTACT SUPPLIER

Antengene Corporation Limited

Antengene Corporation Limited

based inChangning District, CHINA
Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative ...
CONTACT SUPPLIER

Resoundant, Inc.

Resoundant, Inc.

based inRochester, MINNESOTA (USA)
Resoundant, Inc. is a medical technology company founded by Mayo Foundation for Medical Education and Research and is located in Rochester, MN. Resoundant is dedicated to improving patient care and diagnosis accuracy by making Magnetic Resonance ...
CONTACT SUPPLIER

CeramOptec GmbH

CeramOptec GmbH

based inBonn, GERMANY
For more than 30 years, CeramOptec in cooperation with Ceram Optec SIA has been the pioneer in the field of optical fibers. Special fiber optic solutions tailored to your needs: Regardless of the type of application, industry or objectives, we ...
CONTACT SUPPLIER

AVM Biotechnology

AVM Biotechnology

based inSeattle, WASHINGTON (USA)
AVM Biotechnology is developing and advancing AVM0703, a proprietary formulation of concentrated dexamethasone. This formulation permits the very high dosing necessary to activate the release and trigger the production of the body’s supercharged ...
Cancer Treatment Services

Cancer Treatment Services

AVM0703 Induces & Mobilizes Gamma Delta+ NKT-Cells. AVM0703 triggers the production and release of gamma delta+ Natural Killer T-cells (AVM-NKT). These supercharged immune cells have unique properties and appear rapidly in the blood following a ...
CONTACT SUPPLIER

Profound Medical Corp.

Profound Medical Corp.

based inMississauga, ONTARIO (CANADA)
Profound Medical develops customizable, incision-free therapies which combine real-time Magnetic Resonance (MR) imaging, thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased ...
CONTACT SUPPLIER

CASCINATION AG

CASCINATION AG

based inBern, SWITZERLAND
CASCINATION is a Swiss medical device company known for pioneering robotic and image-guided solutions in the healthcare sector. Their technology facilitates minimally invasive procedures, such as tumor ablation and cochlear implantation, ensuring ...
CONTACT SUPPLIER

Accuray

Accuray

based inSunnyvale, CALIFORNIA (USA)
Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond. Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company that develops, ...
TomoTherapy - Image-Guided Radiation Therapy and Intensity-Modulated Radiation Therapy System

TomoTherapy - Image-Guided Radiation Therapy and Intensity-Modulated Radiation Therapy System

Image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT) featuring integrated 3D image guidance, and highly conformal treatments enabled by a unique binary MLC. ...
CONTACT SUPPLIER

IMB Dx, Inc.

IMB Dx, Inc.

based inSeoul, SOUTH KOREA
We detect and analyze genomic profile of tumor DNA with a single draw of blood. With this comprehensive profile, we provide personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Ultimately, we ...
Healthcare Checkup Services

Healthcare Checkup Services

Analysis of cancer-related genes through blood. Through a simple blood draw, key genes related to various cancer types of solid cancers (including gastric, lung, colon, breast, liver, pancreatic, ovarian and uterine cancer, as well as rare cancers ...
CONTACT SUPPLIER

Sumitomo Pharma Oncology, Inc.

Sumitomo Pharma Oncology, Inc.

based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
Dubermatinib - Model (TP-0903) - AXL Inhibitor

Dubermatinib - Model (TP-0903) - AXL Inhibitor

Dubermatinib (TP-0903) is an investigational inhibitor of AXL receptor tyrosine kinase (RTK), a protein known to be involved in acquiring resistance to chemotherapeutics, immune evasion, and developing metastatic capacity in cancer ...
CONTACT SUPPLIER

Elicio Therapeutics

Elicio Therapeutics

based inBoston, MASSACHUSETTS (USA)
We harness the natural power of the lymph nodes to generate enhanced immune responses against tumors. Our science is defining the future of immunotherapy, with the goal of giving patients who are battling cancer their best possible outcome. We’re ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT